Evidence map›Paper›PMID 41710276›Full record

ArticleFrontiers in nutrition2026

Prognostic value of the creatinine-to-albumin ratio for 28-day mortality in patients with sepsis and diabetes: integrating renal and nutritional status in the ICU.

Jianzhu Zhou, Hui Qiu, Jiahui Li, Jiamiao Liu, Chengxian Guo

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jianzhu ZhouCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Hui QiuCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Jiahui LiCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Jiamiao LiuCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.
Chengxian GuoCenter of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patients with sepsis and diabetes exhibit complex pathophysiology that greatly increases the risk of adverse outcomes. This study aimed to investigate the association between CAR and 28-day all-cause mortality among intensive care unit (ICU) patients with sepsis and diabetes mellitus. Methods: In this retrospective cohort study based on the eICU-CRD, we analyzed 1,800 adult patients with sepsis and diabetes mellitus, who were stratified into quartiles by admission CAR. Survival was assessed by Kaplan-Meier analysis. Covariates were selected via LASSO and stepwise regression. Multivariate Cox models evaluated CAR's independent association with mortality. Restricted cubic splines explored nonlinear relationships. ROC analysis and subgroup analyses were performed. Results: Multivariate Cox proportional hazards analysis indicated that CAR was significantly correlated with the 28-day mortality risk in the ICU. Patients in the highest quartile (Q4) had a 4.68-fold greater risk of death compared with those in the lowest quartile [HR 4.68, 95% CI 2.55-8.61, Conclusion: CAR was associated with increased 28-day mortality in ICU patients with sepsis and diabetes. These findings suggest that CAR may be useful for prognosis assessment and risk stratification.

Indexed as

creatinine-to-albumin ratiodiabetes mellitusICU mortalityrenal and nutritional statussepsis

Identifiers

PMID41710276
PMCPMC12909246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.